Song Xiao1, Xiangpeng Zhan1, Tao Chen1, Jingxin Wu1, Linhao Xu1, Ming Jiang1, Wen Deng1, Ke Zhu1, Zhenhao Zeng1, Xiaofeng Cheng1, Qiang Zhou1, Wei Huang1, Xiaochen Zhou1, Cheng Zhang2, Bin Fu3, Gongxian Wang4. 1. Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. 2. Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. zc20021218@126.com. 3. Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. urofbin@163.com. 4. Department of Urology, The First Affiliated Hospital of Nanchang University, Nanchang, China. wanggx-mr@126.com.
Abstract
PURPOSE: To study prognostic values of distal ureter involvement (DUI) and survival outcomes in bladder cancer at T1 and T2 stages. METHODS: The national Surveillance, Epidemiology, and End Results database (2004-2015) was applied to obtain bladder cancer patients. We used the Kaplan-Meier method with the log-rank test, subgroup analyses, the multivariable Cox proportional hazard model and propensity score matching (PSM). RESULTS: A total of 490 patients with DUI and 28,498 patients with non-DUI (non-involvement) were enrolled in our study. After 1:1 PSM, 490 matched pairs were picked out. The multivariable Cox regression before and after PSM revealed that the DUI group had a high risk of overall mortality (HR = 1.374, P < 0.001 before PSM; HR = 1.513, P < 0.001 after PSM) and cancer-specific mortality (HR = 1.632, P < 0.001 before PSM; HR = 1.699, P < 0.001 after PSM). The results of survival analyses showed that patients in the DUI group had lower survival probability in OS (P = 0.0011) and CSS (P < 0.0001) analyses. Nevertheless, in the subgroup analysis, significant differences were only observed in the T1 stage in terms of CSS and T2a stage in terms of OS and CSS (all P < 0.05). CONCLUSION: The prognosis of DUI was poorer than that of non-DUI. DUI was an independent risk factor for OM and CSM in bladder cancer at T1 and T2 stages especially for those at T1 and T2a stages.
PURPOSE: To study prognostic values of distal ureter involvement (DUI) and survival outcomes in bladder cancer at T1 and T2 stages. METHODS: The national Surveillance, Epidemiology, and End Results database (2004-2015) was applied to obtain bladder cancer patients. We used the Kaplan-Meier method with the log-rank test, subgroup analyses, the multivariable Cox proportional hazard model and propensity score matching (PSM). RESULTS: A total of 490 patients with DUI and 28,498 patients with non-DUI (non-involvement) were enrolled in our study. After 1:1 PSM, 490 matched pairs were picked out. The multivariable Cox regression before and after PSM revealed that the DUI group had a high risk of overall mortality (HR = 1.374, P < 0.001 before PSM; HR = 1.513, P < 0.001 after PSM) and cancer-specific mortality (HR = 1.632, P < 0.001 before PSM; HR = 1.699, P < 0.001 after PSM). The results of survival analyses showed that patients in the DUI group had lower survival probability in OS (P = 0.0011) and CSS (P < 0.0001) analyses. Nevertheless, in the subgroup analysis, significant differences were only observed in the T1 stage in terms of CSS and T2a stage in terms of OS and CSS (all P < 0.05). CONCLUSION: The prognosis of DUI was poorer than that of non-DUI. DUI was an independent risk factor for OM and CSM in bladder cancer at T1 and T2 stages especially for those at T1 and T2a stages.
Authors: Oscar Rodriguez Faba; J M Gaya; Alberto Breda; Pablo Juarez Del Dago; Francesca Pisano; Daniel Salas; Juan Palou Journal: J Urol Date: 2016-01-21 Impact factor: 7.450
Authors: Marko Babjuk; Maximilian Burger; Eva M Compérat; Paolo Gontero; A Hugh Mostafid; Joan Palou; Bas W G van Rhijn; Morgan Rouprêt; Shahrokh F Shariat; Richard Sylvester; Richard Zigeuner; Otakar Capoun; Daniel Cohen; José Luis Dominguez Escrig; Virginia Hernández; Benoit Peyronnet; Thomas Seisen; Viktor Soukup Journal: Eur Urol Date: 2019-08-20 Impact factor: 20.096
Authors: Laura Lorenzo Soriano; Guzmán Ordaz Jurado; José Luis Pontones Moreno; Sara Villarroya Castillo; Soraya Hernández Girón; Iván Sáez Moreno; David Ramos Soler Journal: Urology Date: 2019-04-12 Impact factor: 2.649